This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Morten Joersboe: Innovator in Genetic Transformation
Introduction
Morten Joersboe is a notable inventor based in Nykoebing Falster, Denmark. He has made significant contributions to the field of genetic transformation, holding 2 patents that showcase his innovative methods.
Latest Patents
His latest patents include a method for positive selection, which involves selecting genetically transformed cells from a population. This method introduces a desired nucleotide sequence and a co-introduced nucleotide sequence into the genome of a cell. The transformed cells gain a competitive advantage when supplied with an inactive compound, allowing for their identification and selection. Additionally, his invention relates to novel glucuronide compounds, including cytokinin glucuronide compounds, for use in this method. Another patent focuses on mannose or xylose-based positive selection.
Career Highlights
Morten has worked with prominent companies such as Novartis AG and Syngenta Participations AG. His experience in these organizations has contributed to his expertise in genetic research and development.
Collaborations
Throughout his career, Morten has collaborated with notable colleagues, including Kirsten Bojsen and Iain Donaldson. These partnerships have further enhanced his work in the field.
Conclusion
Morten Joersboe's innovative approaches to genetic transformation have made a significant impact in the scientific community. His patents reflect his dedication to advancing the field and improving methods for selecting genetically transformed cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile